Objective: Circulating tumor cells (CTCs) as novel biomarkers are widely investigated in various cancers, although most of the literature shows that CTCs have predictive value for recurrence, metastasis, and prognosis after CRC surgery, results remain controversial. We aimed to systematically evaluate the value of CTCs in monitoring of colorectal cancer (CRC) recurrence and metastasis after surgery.
Method: The PubMed, Cochrane Library, Embase, and other databases were searched from the establishment of the database to May 27, 2021.
Clin Res Hepatol Gastroenterol
September 2021
Background: Previous observational studies regarding the prognostic value of statin on colorectal cancer (CRC) patients showed various results.
Methods: Articles regarding the prognostic value of statin on CRC and published in English and before October 2020 were searched in the following databases: PubMed, Web of Science, EMBASE, Medline and Google Scholar. The multivariate hazard ratios (HRs) and their 95% confidence intervals (CI) were computed to explore associations between statins use and overall mortality or cancer-specific mortality of CRC.